Our findings suggested that targeting Oct4/Nanog-mediated Stat3 signaling pathway may represent a novel approach to overcome EMT process in liver cancer cells displaying stem cell marker properties during tumor progression. This evidence concerns the gene STAT3 and liver cancer.